Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial

BACKGROUND: This study was to evaluate the efficacy and safety of triple fixed-dose combination (FDC) therapy with olmesartan medoxomil (OM) 20  mg, amlodipine (AML) 5 mg, and hydrochlorothiazide (HCTZ) 12.5 mg (OM/AML/HCTZ 20/5/12.5) in Korean patients with moderate hypertension not controlled with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Il Suk, Kim, Chong-Jin, Oh, Byung-Hee, Hong, Taek-Jong, Park, Chang-Gyu, Kim, Byung-Soo, Chung, Woo-Baek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819539/
https://www.ncbi.nlm.nih.gov/pubmed/26691333
http://dx.doi.org/10.1007/s40256-015-0156-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819539/
https://www.ncbi.nlm.nih.gov/pubmed/26691333
http://dx.doi.org/10.1007/s40256-015-0156-x

Ejemplares similares